首页> 外国专利> A method for Controlling the expression of a structural Gene in a cell, DNA constructs for use in said method capable of altering the expressionof The Gene Coding of thrombopoietin.DNase or interferon beta, isolated DNA Molecule, homologamente recombinant cells, Methods for producing those

A method for Controlling the expression of a structural Gene in a cell, DNA constructs for use in said method capable of altering the expressionof The Gene Coding of thrombopoietin.DNase or interferon beta, isolated DNA Molecule, homologamente recombinant cells, Methods for producing those

机译:一种控制细胞中结构基因表达的方法,所述能改变血小板生成素.DNase或干扰素β的基因编码的方法的DNA构建体,分离的DNA分子,同源重组细胞,产生这些基因的方法

摘要

A method for controlling gene expression of cell structure is described, including (a) providing various stages of anti tank structure, including directional insertion sequence, regulation sequence and junction position; (b) An intervening DNA sequence is established between the regulatory sequence and the structural gene, which combines the structural sequence with the structural gene of the corresponding recombinant cell, so that it is in a pre screened position with the gene structure, so as to generate the corresponding recombinant cell;The inserted building adopts a configuration, according to which the regulatory performance is separated from the structural gene, and the length of adn intervenor is pre screened, while the donated bonding site is placed in a way, in the connection after the reprint, RNA cognition and main(c) Control the structural expression of the selected interfering DNA of level (b). The insertion structure in the design at least includes: (a) directional sequence; (b) regulatory sequence; (c) foreign object; and (d) donor connection point. This structure can be repurchased by endogenous cell sequences to generate new genes, which can be imported into cells to generate corresponding recombinant cells. Cells produce a thromboid cellDNase I or interferon Beta. The invention further relates to methods of production of pharmaceutically useful preparations containing thrombopoietin, DNase (I) or beta interferon from cells that are exclusively recombinant and methods of therapy.
机译:描述了一种控制细胞结构的基因表达的方法,包括:(a)提供反坦克结构的各个阶段,包括定向插入序列,调节序列和连接位置; (b)在调控序列和结构基因之间建立一个插入的DNA序列,该结构序列将结构序列与相应重组细胞的结构基因结合在一起,从而使其处于与基因结构预先筛选的位置,从而产生相应的重组细胞;插入的建筑物采用一种配置,根据该配置将调节性能与结构基因分开,并预先筛选adn插入物的长度,同时将捐赠的结合位点以某种方式放置在连接中转载后,RNA认知和main(c)控制选定的(b)级干扰DNA的结构表达。设计中的插入结构至少包括:(a)方向顺序; (b)监管顺序; (c)异物; (d)供体连接点。内源性细胞序列可以重新购买该结构以产生新基因,可以将其导入细胞以产生相应的重组细胞。细胞产生血栓细胞DNase I或干扰素β。本发明进一步涉及从完全重组的细胞生产包含血小板生成素,DNase(I)或β干扰素的药学上有用的制剂的方法和治疗方法。

著录项

  • 公开/公告号AR003112A1

    专利类型

  • 公开/公告日1998-07-08

    原文格式PDF

  • 申请/专利权人 DOCAMPO PALACIOS MAITE L.;

    申请/专利号AR20100175996

  • 发明设计人

    申请日1996-03-15

  • 分类号C12N15/09;C12N15/12;A61K35/12;A61K38;A61K38/21;A61K38/46;A61K48;A61P7;A61P25;A61P27/16;A61P37;C07K14/505;C07K14/52;C07K14/565;C07K14/605;C07K14/61;C12N5/10;C12N9/16;C12N15/19;C12N15/22;C12N15/52;C12N15/67;C12N15/85;C12N15/90;C12P21/02;

  • 国家 AR

  • 入库时间 2022-08-22 02:58:49

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号